(Q36711176)

15 August 2017

1 reference

title

Management of gout in older adults: barriers to optimal control (English)

1 reference

15 August 2017

Karl T Hoskison

1

1 reference

15 August 2017

Robert L Wortmann

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

21-36

1 reference

Does colchicine work? The results of the first controlled study in acute gout.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724010-00002

Synovial fluid analysis for diagnosis of intercritical gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724010-00002

Asymptomatic Hyperuricemia: The Case for Conservative Management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724010-00002

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724010-00002

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724010-00002

Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate

21 January 2018

1 reference

12 December 2020

Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).

1 reference

12 December 2020

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

1 reference

12 December 2020

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

1 reference

12 December 2020

Colchicine induced neuromyopathy in a patient with normal renal function

1 reference

12 December 2020

Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies

1 reference

12 December 2020

An unusual systemic presentation of gout

1 reference

12 December 2020

How well have diagnostic tests and therapies for gout been evaluated?

1 reference

12 December 2020

Withdrawal of longterm antihyperuricemic therapy in tophaceous gout

1 reference

12 December 2020

Alcohol use, comorbidity, and mortality

1 reference

12 December 2020

Gouty tenosynovitis--more common than we think?

1 reference

12 December 2020

Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men

1 reference

12 December 2020

Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout

1 reference

12 December 2020

Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.

1 reference

12 December 2020

Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies

1 reference

12 December 2020

Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis

1 reference

12 December 2020

Current aspects of colchicine therapy -- classical indications and new therapeutic uses

1 reference

12 December 2020

Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol.

1 reference

12 December 2020

Renal transplant-associated hyperuricemia and gout.

1 reference

12 December 2020

Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects

1 reference

12 December 2020

Gout and hyperuricemia

1 reference

12 December 2020

Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch

1 reference

12 December 2020

Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout

1 reference

12 December 2020

Quality of care indicators for gout management

1 reference

12 December 2020

Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension

1 reference

12 December 2020

Outcome measures for acute and chronic gout.

1 reference

12 December 2020

Effective management of gout: an analogy

1 reference

12 December 2020

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

1 reference

12 December 2020

Gouty arthritis. A primer on late-onset gout.

1 reference

12 December 2020

Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout

1 reference

12 December 2020

Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.

1 reference

12 December 2020

Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients

1 reference

12 December 2020

Alcohol intake and risk of incident gout in men: a prospective study

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

1 reference

12 December 2020

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

1 reference

12 December 2020

Tophaceous gout: a clinical and radiographic assessment

1 reference

12 December 2020

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

1 reference

12 December 2020

Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts

1 reference

12 December 2020

Intermittent control of hyperuricemia in the treatment of gout

1 reference

12 December 2020

Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity

1 reference

12 December 2020

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

1 reference

12 December 2020

The optimal use of allopurinol: an audit of allopurinol use in South Auckland

1 reference

12 December 2020

Regulation of renal urate excretion: a critical review.

1 reference

12 December 2020

Colchicine induced rhabdomyolysis

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

1 reference

12 December 2020

Clinical practice. Gout

1 reference

12 December 2020

Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient

1 reference

12 December 2020

Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?

1 reference

12 December 2020

Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study

1 reference

12 December 2020

The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality

1 reference

12 December 2020

Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide

1 reference

12 December 2020

Self-treatment for gout

1 reference

12 December 2020

Efficacy and safety of desensitization to allopurinol following cutaneous reactions

1 reference

12 December 2020

Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout

1 reference

12 December 2020

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

12 December 2020

A literature review of the epidemiology and treatment of acute gout

1 reference

12 December 2020

Review: systemic toxicity associated with the intravenous administration of colchicine--guidelines for use.

1 reference

12 December 2020

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

12 December 2020

Gout, diet, and the insulin resistance syndrome

1 reference

12 December 2020

Investigation and management of gout in the young and the elderly

1 reference

12 December 2020

An approach to hyperuricemia and gout

1 reference

12 December 2020

Update on colchicine and its mechanism of action

1 reference

12 December 2020

Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study

1 reference

12 December 2020

Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study

1 reference

12 December 2020

Systemic steroid therapy for acute gout: a clinical trial and review of the literature

1 reference

12 December 2020

Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis

1 reference

12 December 2020

Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the field

1 reference

12 December 2020

Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout

1 reference

12 December 2020

Colchicine use in cyclosporine treated transplant recipients: how little is too much?

1 reference

12 December 2020

A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis

1 reference

12 December 2020

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.

1 reference

12 December 2020

A comprehensive investigation of inpatient intravenous colchicine use shows more education is needed

1 reference

12 December 2020

ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems

1 reference

12 December 2020

Annual summary of vital statistics: trends in the health of Americans during the 20th century

1 reference

12 December 2020

Azathioprine and allopurinol: a potentially dangerous combination

1 reference

12 December 2020

Clinical manifestations of Korean female gouty patients

1 reference

12 December 2020

Obesity and the metabolic syndrome in children and adolescents

1 reference

12 December 2020

Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults

1 reference

12 December 2020

Gout: can management be improved?

1 reference

12 December 2020

Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system.

1 reference

12 December 2020

Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population

1 reference

12 December 2020

Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis

1 reference

12 December 2020

Serum urate and the risk of major coronary heart disease events.

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

12 December 2020

Epidemiology, risk factors, and lifestyle modifications for gout

1 reference

12 December 2020

Long-term efficacy of hyperuricaemia treatment in renal transplant patients

1 reference

12 December 2020

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

1 reference

12 December 2020

Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis.

1 reference

12 December 2020

Gout and the risk of acute myocardial infarction

1 reference

12 December 2020

The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients

1 reference

12 December 2020

10.2165/00002512-200724010-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1017674530

0 references

1 reference